Israeli precision medicine co DayTwo raises $37m
DayTwo uses AI, the sequencing of the gut microbiome and other clinical measures to create precision nutrition-based food prescriptions to balance blood sugar levels after meals.
Israeli precision medicine company DayTwo has raised $37 million to continue development of technologies and solutions designed to improve the health of people with diabetes and other metabolic diseases. DayTwo’s existing investors participated in this latest financing round including aMoon of Marius Nacht and Dr. Yair Schindel, 10D of Yahal Zilka, and Cathay Innovation Ventures. They were joined by new investors, including Poalim Capital Markets, La’maison Fund and Micron Ventures. This round brings the total amount invested in DayTwo to $85 million.
Over $1B in one day: How Israeli startups are setting new funding records geektime.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geektime.com Daily Mail and Mail on Sunday newspapers.